+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 56 Pages
  • November 2024
  • Region: Global
  • GlobalData
  • ID: 5790961
The Medical Devices sector report, “Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Thoracic Aortic Stent Grafts Overview
3 Products under Development
3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies
4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
5 Thoracic Aortic Stent Grafts Companies and Product Overview
6 Thoracic Aortic Stent Grafts- Recent Developments
6.1 Oct 31, 2024: LeMaitre Reports Q3 2024 Results
6.2 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
6.3 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024
6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
6.6 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
6.7 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs
6.9 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials
  • Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • APT Medical Inc
  • Artivion Inc
  • Beijing Tianzhu Ruichang Medical Technology Co Ltd
  • EndoSpan Ltd
  • Evasc Medical Systems Corp
  • Hangzhou Endonom Medtech Co Ltd
  • JOTEC GmbH
  • Lombard Medical Technologies Inc.
  • Medtronic Plc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical LLC
  • Terumo Aortic
  • The Lundquist Institute
  • TriVascular Inc
  • University of Kentucky
  • Zylox-Tonbridge Medical Technology Co Ltd